The estimated Net Worth of Queena Han is at least $1.45 Milion dollars as of 1 September 2020. Ms. Han owns over 57,692 units of XBiotech Inc stock worth over $373,267 and over the last 9 years she sold XBIT stock worth over $0. In addition, she makes $1,073,530 as Vice President - Finance and Human Resources a Secretary at XBiotech Inc.
Sign up
Ms. Han XBIT stock SEC Form 4 insiders trading
Queena has made over 7 trades of the XBiotech Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently she exercised 57,692 units of XBIT stock worth $242,306 on 1 September 2020.
The largest trade she's ever made was exercising 80,000 units of XBiotech Inc stock on 21 March 2018 worth over $200,000. On average, Queena trades about 20,069 units every 143 days since 2015. As of 1 September 2020 she still owns at least 57,692 units of XBiotech Inc stock.
You can see the complete history of Ms. Han stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Queena Han biography
Queena Clark Han C.P.A. serves as Vice President - Finance and Human Resources, Secretary of the Company.G.A. serves as Vice President - Finance and Human Resources, Secretary of the Company. She has been employed by XBiotech since April 2008 beginning as our controller, and was promoted to Vice President of Finance and Human Resources and Secretary in June 2012. Prior to joining XBiotech, she served as Chief Financial Officer (CFO) for a public company with a nation-wide pay phone hardware and service business. Ms. Han has a B.A. in accounting, holds a Chartered Professional Accountants designation in Canada, is a professional member of SHRM and holds the Human Resource Management Certification from the University of Texas at Austin.
What is the salary of Queena Han?
As the Vice President - Finance and Human Resources a Secretary of XBiotech Inc, the total compensation of Queena Han at XBiotech Inc is $1,073,530. There are 3 executives at XBiotech Inc getting paid more, with John Simard having the highest compensation of $10,810,400.
How old is Queena Han?
Queena Han is 52, she's been the Vice President - Finance and Human Resources a Secretary of XBiotech Inc since 2012. There are 7 older and 2 younger executives at XBiotech Inc. The oldest executive at XBiotech Inc is Peter Libby, 73, who is the Independent Director.
What's Queena Han's mailing address?
Queena's mailing address filed with the SEC is 5217 WINNEBAGO LANE, , AUSTIN, TX, 78744.
Insiders trading at XBiotech Inc
Over the last 9 years, insiders at XBiotech Inc have traded over $50,443,920 worth of XBiotech Inc stock and bought 1,428,502 units worth $11,921,113 . The most active insiders traders include Street Financial S.A. Bay, Fondation Rennes a W Thorpe Mckenzie. On average, XBiotech Inc executives and independent directors trade stock every 48 days with the average trade being worth of $1,053,782. The most recent stock trade was executed by W Thorpe Mckenzie on 16 December 2021, trading 250,000 units of XBIT stock currently worth $2,500,000.
What does XBiotech Inc do?
xbiotech is developing a first-in-class monoclonal antibody (mabp1) to inhibit chronic inflammation. chronic (sterile) inflammatory responses are involved in the progression of many serious and common diseases. mabp1 is being investigated in many important areas of medicine, including: cancer, leukemia (phase 1); type 2 diabetes (phase2); psoriasis (phase 2); and vascular disease (phase 2). mabp1 is a true human™ antibody cloned from a natural human immune response and—unlike currently marketed antibodies—it has not undergone any modification to alter its function. it has exhibited the best potential tolerability and safety during the clinical trials. xbiotech has established a current good manufacturing practices (cgmp) program to commercialize its lead product candidate. the company has purchased land and designed a commercial-scale plant with 25,000l total bioreactor capacity. construction of the facility is planned to commence in 4th quarter 2011..
What does XBiotech Inc's logo look like?
Complete history of Ms. Han stock trades at XBiotech Inc
XBiotech Inc executives and stock owners
XBiotech Inc executives and other stock owners filed with the SEC include:
-
John Simard,
Chairman of the Board, President, Chief Executive Officer, Founder -
John Simard,
Founder, Pres, CEO & Chairman -
Sushma Shivaswamy,
Chief Scientific Officer -
Queena Han,
Vice President - Finance and Human Resources, Secretary -
Dr. Sushma Shivaswamy,
Chief Scientific Officer -
Queena Han CPA, B.A., CPA, C.G.A.,
VP of Fin. & HR and Sec. -
W. Thorpe McKenzie,
Independent Director -
Donald MacAdam,
Independent Director -
Peter Libby,
Independent Director -
Jan-Paul Waldin,
Lead Independent Director -
Lisa Simard,
Director of Corp. Strategy - XBiotech USA, Inc. -
BenjamÃn Guzmán,
Sr. VP of Corp. Strategy & Fin. -
Daniel Vasella,
Director -
Trey Benson,
VP of Commercial Development -
Kelly Thornburg,
SVP of Operations -
Fabrizio Bonanni,
Director -
Dawn Mc Collough,
VP Clinical Operations -
Michael Stecher,
Medical Director -
Kalidip Choudhury,
VP of Business Development -
James Scott Whitehurst,
Chief Financial Officer -
Thomas Gut,
10% owner -
Benjamin Guzman,
Sr.VP Corp. Strategy & Finance -
Fondation Rennes,
10% owner -
Street Financial S.A. Bay,
10% owner